Metabolic syndrome update

SM Grundy - Trends in cardiovascular medicine, 2016 - Elsevier
The metabolic syndrome is a multiplex risk factor for atherosclerotic cardiovascular disease
and type 2 diabetes. It is composed of atherogenic dyslipidemia, elevated blood pressure …

COSMIC project: consensus on the objectives of the metabolic syndrome in clinic

J Pedro-Botet, JF Ascaso, V Barrios… - … syndrome and obesity …, 2018 - Taylor & Francis
Metabolic syndrome (MetS), a disorder with a high and growing prevalence, is a recognized
risk factor for cardiovascular disease (CVD) and type 2 diabetes. It is a constellation of …

[HTML][HTML] Circular RNA expression profiles in plasma from patients with heart failure related to platelet activity

Y Sun, X Jiang, Y Lv, X Liang, B Zhao, W Bian… - Biomolecules, 2020 - mdpi.com
Heart failure (HF) is a deadly disease that is difficult to accurately diagnose. Circular RNAs
(circRNAs) are a novel class of noncoding RNAs that might play important roles in many …

Platelet–Lymphocyte Ratio, Neutrophil–Lymphocyte Ratio and Their Dynamic Changes with Type 2 Diabetes Mellitus: A Cohort Study in China

C Zhang, H Chen, S Cui, Y Lin, Y Liang… - Endocrine …, 2022 - Taylor & Francis
Background This study aimed at investigating the relationships between Platelet-
Lymphocyte ratio (PLR) and Neutrophil–Lymphocyte ratio (NLR) and their dynamic changes …

The vulnerable blood

K Hess - Hämostaseologie, 2015 - thieme-connect.com
Patients with diabetes are at increased risk of cardiovascular morbidity and mortality. While
arteriosclerotic lesions have long been recognized as the underlying cause more recent …

Effects of subcutaneous vs. oral nanoparticle-mediated insulin delivery on hemostasis disorders in type 1 diabetes: A rat model study

N Kaddour, F Benyettou, K Moulai, A Mebarki… - Heliyon, 2024 - cell.com
Complications associated with Type 1 diabetes (T1D) have complex origins that revolve
around chronic hyperglycemia; these complications involve hemostasis disorders …

Prognostic significance of plasma insulin level for deep venous thrombosis in patients with severe traumatic brain injury in critical care

M Du, QH Zhang, R Tang, HY Liu, ZS Ji, Z Gao… - Neurocritical Care, 2023 - Springer
Background Whether insulin resistance underlies deep venous thrombosis (DVT)
development in patients with severe traumatic brain injury (TBI) is unclear. In this study, the …

Glucose inhibits haemostasis and accelerates diet-induced hyperlipidaemia in zebrafish larvae

S Morris, PM Cholan, WJ Britton, SH Oehlers - Scientific Reports, 2021 - nature.com
Hyperglycaemia damages the microvasculature in part through the reduced recruitment of
immune cells and interference with platelet signalling, leading to poor wound healing and …

Nuclear factor-κB regulates expression of platelet phospholipase C-β2 (PLCB2)

G Mao, J **, SP Kunapuli… - Thrombosis and …, 2016 - thieme-connect.com
Phospholipase C (PLC)-β2 (gene PLCB2) is a critical regulator of platelet responses upon
activation. Mechanisms regulating of PLC-β2 expression in platelets/MKs are unknown. Our …

Covid-19 and metabolic syndrome

PR Chocair, PDMM Neves, LVB Pereira… - Revista da Associacao …, 2020 - SciELO Brasil
In the second half of 2019, a new coronavirus (Sars-Cov-2) was identified in a city of China,
which soon spread to the whole world, becoming a great tragedy and reaching all …